Author:
Howard Carolyn,Samuel Jacqueline,Henderson Shalonda,Stevens Jacqueline,Thomas Paul,Cuchens Marvin
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference34 articles.
1. In vitro mutagenicity of the plasmacytomagenic agent pristane (2, 6, 10, 14-tetramethylpentadecane);Felix;Cancer Lett,1997
2. Elevated mutant frequencies in lymphoid tissues persist throughout plasmacytoma development in BALB/c.lambdaLIZ mice;Felix;Cancer Res,1999
3. Myeloma proteins that bind Hsp65 (GroEL) are polyreactive and are found in high incidence in pristine induced plasmacytomas;Potter;Curr. Top. Microbiol. Immunol,2000
4. Selenium deficiency abrogates inflammation-dependent plasma cell tumors in mice;Felix;Cancer Res,2004
5. BALB/c.CBA/N mice carrying the defective Btkxid gene are resistant to pristine-induced plasmacytomagenesis;Potter;Internat. Immunol,1999